We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: JPMorgan, Shopify, PetroChina, Union Pacific, and Moderna
Read MoreHide Full Article
For Immediate Release
Chicago, IL – October 28, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. (JPM - Free Report) , Shopify Inc. (SHOP - Free Report) , PetroChina Company Ltd. , Union Pacific Corp. (UNP - Free Report) and Moderna, Inc. (MRNA - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for JPMorgan, Shopify and PetroChina
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co., Shopify Inc., and PetroChina Company Ltd. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of JPMorgan have underperformed the Zacks Major Regional Banks industry over the past year (+79.5% vs. +92.3%), however, things seem to be improving for it. The Zacks analyst believes that business diversification efforts, strategic add-on acquisitions, a strong liquidity position, and initiatives to expand the branch network in new markets are some of the major tailwinds for the company.
Such efforts are likely to enhance shareholder value. Lower interest rates and the Fed’s decision to keep rates unchanged in the near term, however, are expected to weigh on the company’s margins and interest income. Normalization of the trading business is another headwind for the company.
Shopify shares have gained 19.1% in the year to date period against the Zacks Internet Services industry’s gain of +35.7%. The company is benefiting from an e-commerce boom induced growth in the merchant base. The Zacks analyst believes that focus on developing merchant base, international expansion, addition of fulfillment network functionalities, and rich partner ecosystem are the key catalysts for growth.
Robust uptick in Shopify Shipping, Shopify Payments and Shopify Capital has been driving the top line as reflected by the second quarter results. Partnerships with Facebook and Google are expected to expand the merchant base further. Steadily increasing operational expenses and stretched valuation are primary concerns for the company though.
Shares of PetroChina have gained +48.3% over the past six months against the Zacks International Integrated Oil industry’s gain of +22.2%. The Zacks analyst believes that its natural gas business is poised to gain significantly in the coming years as China moves from coal to natural gas.
Strong growth in China’s middle class, and consequently in automobile ownership, is expected to fuel consumption of refined petroleum products. PetroChina’s downstream division is set to gain from it. Higher oil prices are expected to support the company’s upstream unit too in the near-to-medium term. Volatility in commodity prices, stiff competition from domestic and international peers and regulatory constraints are likely to weigh on the margins though.
Other noteworthy reports we are featuring today include Union Pacific Corp. and Moderna, Inc.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: JPMorgan, Shopify, PetroChina, Union Pacific, and Moderna
For Immediate Release
Chicago, IL – October 28, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. (JPM - Free Report) , Shopify Inc. (SHOP - Free Report) , PetroChina Company Ltd. , Union Pacific Corp. (UNP - Free Report) and Moderna, Inc. (MRNA - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for JPMorgan, Shopify and PetroChina
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co., Shopify Inc., and PetroChina Company Ltd. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of JPMorgan have underperformed the Zacks Major Regional Banks industry over the past year (+79.5% vs. +92.3%), however, things seem to be improving for it. The Zacks analyst believes that business diversification efforts, strategic add-on acquisitions, a strong liquidity position, and initiatives to expand the branch network in new markets are some of the major tailwinds for the company.
Such efforts are likely to enhance shareholder value. Lower interest rates and the Fed’s decision to keep rates unchanged in the near term, however, are expected to weigh on the company’s margins and interest income. Normalization of the trading business is another headwind for the company.
(You can read the full research report on JPMorgan here >>>)
Shopify shares have gained 19.1% in the year to date period against the Zacks Internet Services industry’s gain of +35.7%. The company is benefiting from an e-commerce boom induced growth in the merchant base. The Zacks analyst believes that focus on developing merchant base, international expansion, addition of fulfillment network functionalities, and rich partner ecosystem are the key catalysts for growth.
Robust uptick in Shopify Shipping, Shopify Payments and Shopify Capital has been driving the top line as reflected by the second quarter results. Partnerships with Facebook and Google are expected to expand the merchant base further. Steadily increasing operational expenses and stretched valuation are primary concerns for the company though.
(You can read the full research report on Shopify here >>>)
Shares of PetroChina have gained +48.3% over the past six months against the Zacks International Integrated Oil industry’s gain of +22.2%. The Zacks analyst believes that its natural gas business is poised to gain significantly in the coming years as China moves from coal to natural gas.
Strong growth in China’s middle class, and consequently in automobile ownership, is expected to fuel consumption of refined petroleum products. PetroChina’s downstream division is set to gain from it. Higher oil prices are expected to support the company’s upstream unit too in the near-to-medium term. Volatility in commodity prices, stiff competition from domestic and international peers and regulatory constraints are likely to weigh on the margins though.
(You can read the full research report on PetroChina here >>>)
Other noteworthy reports we are featuring today include Union Pacific Corp. and Moderna, Inc.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.